The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation

Oral Oncology

Volumn 48, Issue 9, 2012, Pages 822-830

  Ettl, Tobias ^a   Schwarz Furlan, Stephan ^b   Haubner, Frank ^a   Müller, Steffen ^a   Zenk, Johannes ^b   Gosau, Martin ^a   Reichert, Torsten E ^a   Zeitler, Katharina ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

AKT; mTOR; PI3K; Prognosis; S6rp; Salivary gland cancer

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN S6;

ACINAR CELL CARCINOMA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY GLAND CANCER; SCHOOL CHILD; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR VOLUME;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; SALIVARY GLAND NEOPLASMS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TOR SERINE-THREONINE KINASES;

EID: 84865187285     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.02.021     Document Type: Article

References (39)

1. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 7 2002 489 501 (Pubitemid 37328931)
2. J.A. Engelman Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nat Rev Cancer 9 8 2009 550 562
3. D.C. Fingar, C.J. Richardson, A.R. Tee, L. Cheatham, C. Tsou, and J. Blenis MTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E Mol Cell Biol 24 1 2004 200 216 (Pubitemid 38010048)
4. A. Dufner, and G. Thomas Ribosomal S6 kinase signaling and the control of translation Exp Cell Res 253 1 1999 100 109
5. J. Luo, B.D. Manning, and L.C. Cantley Targeting the PI3K-Akt pathway in human cancer: rationale and promise Cancer Cell 4 4 2003 257 262 (Pubitemid 37329790)
6. K.D. Courtney, R.B. Corcoran, and J.A. Engelman The PI3K pathway as drug target in human cancer J Clin Oncol 28 6 2010 1075 1083
7. L. Barnes, J.W. Eveson, P. Reichart, and D. Sidransky Pathology and genetics of head and neck tumours. World Health Organization classification of tumours 2005 IARC Press Lyon
8. L.H. Sobin, and C. Wittekind TNM: classification of malignant tumours 6th ed. 2002 John Wiley & Sons New York
9. S. Schwarz, C. Stiegler, M. Muller, T. Ettl, G. Brockhoff, and J. Zenk Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation Histopathology 58 4 2011 557 570
10. E. Jouzdani, J. Yachouh, V. Costes, J.L. Faillie, C. Cartier, and F. Poizat Prognostic value of a three-grade classification in primary epithelial parotid carcinoma: result of a histological review from a 20-year experience of total parotidectomy with neck dissection in a single institution Eur J Cancer 46 2 2010 323 331
11. M.H. Therkildsen, M. Christensen, L.J. Andersen, T. Schiodt, and H.S. Hansen Salivary gland carcinomas-prognostic factors Acta Oncol 37 7-8 1998 701 713
12. R.K. Goode, and A.K. El-Naggar Mucoepidermoid carcinoma L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky, Pathology and genetics of head and neck tumours. World Health Organization Classification of Tumours 2005 IARC Press Lyon 219 220
13. A.K. El-Naggar, and A.G. Huvos Adenoid cystic carcinoma L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky, Pathology and genetics of head and neck tumours. World Health Organization Classification of Tumours 2005 IARC Press Lyon 221 222
14. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 5 1991 403 410
15. M. Milanes-Yearsley, M.E. Hammond, T.F. Pajak, J.S. Cooper, C. Chang, and T. Griffin Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups Mod Pathol 15 12 2002 1366 1373 (Pubitemid 35463006)
16. T. Murayama, M. Inokuchi, Y. Takagi, H. Yamada, K. Kojima, and J. Kumagai Relation between outcomes and localisation of p-mTOR expression in gastric cancer Br J Cancer 100 5 2009 782 788
17. A. Carnero The PKB/AKT pathway in cancer Curr Pharm Des 16 1 2010 34 44
18. J. Woenckhaus, K. Steger, K. Sturm, K. Munstedt, F.E. Franke, and I. Fenic Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer Virchows Arch 450 4 2007 387 395 (Pubitemid 46466383)
19. A.J. Pantuck, D.B. Seligson, T. Klatte, H. Yu, J.T. Leppert, and L. Moore Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy Cancer 109 11 2007 2257 2267 (Pubitemid 46801555)
20. S.L. Wyszomierski, and D. Yu A knotty turnabout? Akt1 as a metastasis suppressor Cancer Cell 8 6 2005 437 439 (Pubitemid 41773446)
21. H.Y. Irie, R.V. Pearline, D. Grueneberg, M. Hsia, P. Ravichandran, and N. Kothari Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition J Cell Biol 171 6 2005 1023 1034 (Pubitemid 41815834)
22. Y.R. Chin, and A. Toker Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer Cell Signal 21 4 2009 470 476
23. M. Yoeli-Lerner, Y.R. Chin, C.K. Hansen, and A. Toker Akt/protein kinase b and glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor Mol Cancer Res 7 3 2009 425 432
24. H. Liu, D.C. Radisky, C.M. Nelson, H. Zhang, J.E. Fata, and R.A. Roth Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2 Proc Natl Acad Sci U S A 103 11 2006 4134 4139
25. A. Toker, and M. Yoeli-Lerner Akt signaling and cancer: surviving but not moving on Cancer Res 66 8 2006 3963 3966
26. M. Yoeli-Lerner, G.K. Yiu, I. Rabinovitz, P. Erhardt, S. Jauliac, and A. Toker Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT Mol Cell 20 4 2005 539 550 (Pubitemid 41668639)
27. J.N. Hutchinson, J. Jin, R.D. Cardiff, J.R. Woodgett, and W.J. Muller Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion Cancer Res 64 9 2004 3171 3178 (Pubitemid 38581419)
28. N. Abe, J. Watanabe, S. Tsunoda, H. Kuramoto, and I. Okayasu Significance of nuclear p-Akt in endometrial carcinogenesis: rapid translocation of p-Akt into the nucleus by estrogen, possibly resulting in inhibition of apoptosis Int J Gynecol Cancer 21 2 2011 194 202
29. J. Lim, J.H. Kim, J.Y. Paeng, M.J. Kim, S.D. Hong, and J.I. Lee Prognostic value of activated Akt expression in oral squamous cell carcinoma J Clin Pathol 58 11 2005 1199 1205 (Pubitemid 41566467)
30. D.L. Dai, M. Martinka, and G. Li Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases J Clin Oncol 23 7 2005 1473 1482
31. K.S. Chadha, T. Khoury, J. Yu, J.D. Black, J.F. Gibbs, and B.W. Kuvshinoff Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma Ann Surg Oncol 13 7 2006 933 939
32. F. Cappuzzo, F.R. Hirsch, E. Rossi, S. Bartolini, G.L. Ceresoli, and L. Bemis Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer J Natl Cancer Inst 97 9 2005 643 655 (Pubitemid 40812628)
33. A. Shah, W.A. Swain, D. Richardson, J. Edwards, D.J. Stewart, and C.M. Richardson Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer Clin Cancer Res 11 8 2005 2930 2936 (Pubitemid 40525195)
34. S. Ikeda, K. Takabe, M. Inagaki, and K. Suzuki Expression of phosphorylated Akt in patients with small cell carcinoma of the lung indicates good prognosis Pathol Int 60 11 2010 714 719
35. M.M. Javle, J. Yu, T. Khoury, K.S. Chadha, R.V. Iyer, and J. Foster Akt expression may predict favorable prognosis in cholangiocarcinoma J Gastroenterol Hepatol 21 11 2006 1744 1751 (Pubitemid 44410889)
36. Y. Baba, K. Nosho, K. Shima, M. Hayashi, J.A. Meyerhardt, and A.T. Chan Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers Cancer 117 7 2011 1399 1408
37. C. Cinti, C. Vindigni, A. Zamparelli, D. La Sala, M.C. Epistolato, and D. Marrelli Activated Akt as an indicator of prognosis in gastric cancer Virchows Arch 453 5 2008 449 455
38. C.R. Diegel, K.R. Cho, A.K. El-Naggar, B.O. Williams, and C. Lindvall Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma Cancer Res 70 22 2010 9143 9152
39. S.M. McBride, D.A. Perez, M.Y. Polley, S.R. Vandenberg, J.S. Smith, and S. Zheng Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival J Neurooncol 97 1 2010 33 40